AirSculpt® Technologies, Inc. Announces Completion of Debt Refinancing
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
AirSculpt Technologies, Inc. (NASDAQ: AIRS) has announced a new credit agreement with lenders, securing $85 million in term loans and a $5 million revolving loan facility. This funding will pay off an existing $83.6 million credit facility due October 28, 2023. The new agreement, maturing on November 7, 2027, is expected to save the company approximately $2 million annually in cash interest, with no prepayment penalties. CFO Dennis Dean expressed satisfaction with the refinancing, noting it provides flexibility to pursue strategic growth plans.
Positive
- Secured $85 million in term loans and a $5 million revolving loan facility.
- Expected cash interest savings of approximately $2 million annually.
- No prepayment penalties under the new credit agreement.
Negative
- None.
Details
News Market Reaction – AIRS
The recorded move for AIRS in the trading session of this news was -5.41%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIAMI BEACH, Fla., Nov. 09, 2022 (GLOBE NEWSWIRE) -- AirSculpt® Technologies, Inc., (“AirSculpt” or the “Company”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced that it has entered into a new credit agreement with several new lenders. The new credit agreement consists of (i) an
“I am extremely pleased we were able to execute this refinancing with favorable terms in this challenging economic environment. Our new capital structure gives us plenty of flexibility and positions us well to continue to execute on our strategic growth plans,” said Dennis Dean, Chief Financial Officer.
About AirSculpt®
AirSculpt® Technologies (NASDAQ: AIRS) is an experienced, fast-growing national provider of body contouring procedures delivering a premium consumer experience under its brand, Elite Body Sculpture. At Elite Body Sculpture, we provide custom body contouring using our proprietary AirSculpt® method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. It is our mission to generate the best results for our patients.
Investor Contact:
Dennis Dean
Chief Financial Officer
investors@elitebodysculpture.com
Media Contact:
Stephanie Evans Greene
Chief Marketing Officer
sevansgreene@elitebodysculpture.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.